Rachel Haurwitz, Caribou CEO (Kimberly White/Getty Images for TechCrunch)
A Jennifer Doudna-launched upstart nabs $115M for off-the-shelf CAR-Ts
There is no shortage of biotechs pursuing off-the-shelf CAR-Ts, a so-called Holy Grail in oncology R&D. Now, less than a month after teaming up with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.